Fresenius Bid To Save Diprivan Patent Denied By Fed. Circ.
The Federal Circuit shot down an effort by Fresenius Kabi USA to salvage a patent on Diprivan, siding on Wednesday with financier Kyle Bass in his push to invalidate claims over...To view the full article, register now.
Already a subscriber? Click here to view full article